Chinese Stocks Surge As Investors Bet On Economic Turnaround: 7 ETFs To Watch
Chinese stocks have rallied 19% from 2024 lows, fueled by economic recovery & improved private sector activity. Overestimation of recovery is a risk.
Boeing Cargo Plane’s Daring Gearless Landing In Istanbul, Investigation Underway
Boeing 767 cargo plane makes emergency landing at Istanbul Airport due to front landing gear malfunction. No casualties reported. Turkish Transport Ministry investigates. FedEx pledges cooperation amid Boeing's management restructuring.
Why Broadridge Financial Shares Are Diving Today
Broadridge Financial Solutions reported Q3 FY24 results with 5% revenue growth, missing consensus. Adjusted EPS of $2.23 (-9% Y/Y) missed expectations. FY24 outlook for recurring revenue growth at low end of prior guidance.
Why Energy Company HF Sinclair Shares Are Surging Wednesday
HF Sinclair reported Q1 FY24 results, with revenues down 7% and adjusted EBITDA down 43%. Company declared $0.50 dividend and announced $1 billion buyback.
Emerson Electrifies Q2 With Earnings Beat, Tightens FY Sales Growth Outlook
Emerson Electric Co (EMR) reported 17% net sales growth in Q2 FY24, beating expectations. Adjusted EPS improved by 25%, and dividend declared.
China’s Autohome Floors It On Sales, User-Base: Details
Autohome reports Q1 FY24 revenues of RMB1,609.1M, beating consensus of $220.6M. Adjusted net income of RMB493.9M. CEO highlights user growth and expansion of new businesses.
Apple’s New M4 iPads: ‘More Powerful Than Any AI PC’ Today, Set To Boost Sales
Apple Inc. updates iPad lineup with new Pro and Air models featuring advanced M4 and M2 chips, signaling growth potential and boosting revenue mix.
Biden Administration Tightens Grip On China’s Huawei, Revokes Key Export Licenses From US Chipmakers
The Biden admin revoked export licenses to Intel and Qualcomm, escalating US efforts to curb Huawei's tech ascent due to national security concerns.
Johnson & Johnson’s TARIS Platform – Goldman Sachs Outlines Potential For The Bladder Cancer Therapy
Johnson & Johnson unveils promising TARIS platform data for bladder cancer treatment, highlighting ease of administration and significant revenue potential.
Dental Supplies Distributor Henry Schein’s Tech Segment Provides Some Stability In Challenging Macro Times: Analyst
Henry Schein reports Q1 adjusted EPS at $1.10, down 9% Y/Y, with sales at $3.17 billion, up 3.7%. Guidance projects 2024 sales growth at 8%-10%, reaffirming adjusted EPS guidance of $5.00-$5.16. William Blair attributes the EPS beat to margin expansion driven by technology and value-added services.